Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$244K Buy
745
+1
+0.1% +$317 0.07% 33
2025
Q3
$210K Buy
744
+2
+0.3% +$580 0.07% 42
2025
Q2
$207K Buy
742
+1
+0.1% +$283 0.09% 36
2025
Q1
$231K Buy
+741
New +$219K 0.13% 27
2024
Q3
Sell
-641
Closed -$200K 25
2024
Q2
$200K Buy
+641
New +$188K 0.11% 24

Other funds holding AMGN

Lanham O'Dell & Company's AMGN Position: Q4 2025 in Review

Lanham O'Dell & Company increased its Amgen (AMGN) stake by 0.13% in Q4 2025, buying an estimated $317 and bringing the position to 745 shares worth $244K. The position accounts for 0.07% of the portfolio, ranked #33.

Lanham O'Dell & Company first reported a position in AMGN in Q2 2024 and has held it in 5 quarters since. 3,086 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Lanham O'Dell & Company held 745 shares of Amgen worth $244K as of Q4 2025.
  • Lanham O'Dell & Company bought 1 Amgen share in Q4 2025, an estimated $317.
  • Amgen made up 0.07% of Lanham O'Dell & Company's portfolio in Q4 2025, its #33 holding.
  • Lanham O'Dell & Company first reported a position in Amgen in Q2 2024 and has held it in 5 quarters since.
  • 3,086 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Lanham O'Dell & Company's 13F filing for Q4 2025, filed 12 Jan 2026.